← Leaderboards
Mark A. Malangoni
Case Western Reserve University
$38,398
Attributed
$38,398
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$38,398 · 2
By mechanism
M01$38,398 · 2
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Scot C Remick$11,938,221
- Katherine L. Wisner$16,545,298
- Susann M Brady-Kalnay$13,129,878
- Zheng-Rong Lu$13,267,567
- Michael W. Konstan$52,389,820
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationHuman Therapy EvaluationHuman SubjectClinical ResearchPharmacokineticsInfectionAntibioticsPlacebosCardiovascular Disorder ChemotherapyCell Adhesion MoleculesDrug Adverse EffectHemorrhagic ShockMultiple Organ Failure
Grant awards (4)
IV ALATROFLOXACIN FOR TREATMENT OF COMPLICATED INTRAABDOMINAL INFECTI$0
M01 · FY2002 · RR
IV ALATROFLOXACIN FOR TREATMENT OF COMPLICATED INTRAABDOMINAL INFECTI$0
M01 · FY2001 · RR
IV ALATROFLOXACIN FOR TREATMENT OF COMPLICATED INTRAABDOMINAL INFECTI$19,199
M01 · FY2000 · RR
HEMORRHAGIC SHOCK$19,199
M01 · FY2000 · RR